 Home > Active Ingredient News > Antitumor Therapy > Gastric Cancer: Phase 3 | The efficacy of fluorouracil/thiopiperidine in the treatment of metastatic gastroesophageal junction cancer

Gastric Cancer: Phase 3 | The efficacy of fluorouracil/thiopiperidine in the treatment of metastatic gastroesophageal junction cancer

 Last Update: 2021-03-20
 Source: Internet
 Author: User

Tags

essential oils cause cancer

adenocarcinoma prostate cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The survival prognosis of patients with advanced gastroesophageal junction cancer (GEJC) is poor; there is currently a lack of clinical trial data specific to GEJC, and most of the existing data are derived fromThe overall evaluation of gastric cancer (GC) treatment drugs.

Stomach cancer

This article reports the results of a subgroup analysis of the primary tumor type (GC or GEJC) in the TAGS trial.

The TAGS trial recruited mGC or mGEJC patients who had previously been treated with 2-line or above chemotherapy, and were randomized (2:1) to receive FTD/TPI or placebo treatment, while giving the best supportive treatment.

Baseline characteristics of the patient

A total of 507 patients were recruited, including 145 (29%) GEJC and 360 (71%) GC.

Efficacy prognosis in GEJC and GC groups

The survival benefit of FTD/TPI treatment was observed in both subgroups.

Compared with placebo, in the GEJC and GC subgroups, the overall survival risk ratio of FTD/TPI was 0.

Time before deterioration

In the GEJC and GC subgroups, 75 patients (77%) and 192 patients (81%) who received FTD/TPI treatment, respectively, reported adverse events ≥ Grade 3 caused by any cause.

No new security issues with FTD/TPI found

In summary, in the TAGS trial, as in GC patients, FTD/TPI also showed efficacy advantages and controllable safety in GEJC patients.

In the TAGS trial, as in GC patients, FTD/TPI also showed efficacy advantages and controllable safety in GEJC patients.

Original source:

Mansoor, W.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.